Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Bober SL"'
Publikováno v:
Journal of Pain Research, Vol Volume 9, Pp 735-744 (2016)
Gordon D Ko,1,2 Sara L Bober,1 Sean Mindra,3 Jason M Moreau1 1Apollo Applied Research Inc., 2Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, 3University of Ottawa Medical School, Ottawa, ON, Canada Abstract:
Externí odkaz:
https://doaj.org/article/4eaa07110ae34cf98482e76ebb4ac1df
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Merport A, Bober SL, Grose A, Recklitis CJ, Merport, Anna, Bober, Sharon L, Grose, Amy, Recklitis, Christopher J
Publikováno v:
Supportive Care in Cancer; Jan2012, Vol. 20 Issue 1, p195-198, 4p
Publikováno v:
Journal of Genetic Counseling; Dec2007, Vol. 16 Issue 6, p755-762, 8p
Autor:
Bober SL, Park ER, Schmookler T, Medeiros Nancarrow C, Diller L, Bober, Sharon L, Park, Elyse R, Schmookler, Terra, Medeiros Nancarrow, Cheryl, Diller, Lisa
Publikováno v:
Journal of Cancer Education; Spring2007, Vol. 22 Issue 1, p42-46, 5p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bober SL
Publikováno v:
Cancer Journal; Jan/Feb2009, Vol. 15 Issue 1, p13-14, 2p
Autor:
Chevalier LL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, USA.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA., McCormick K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Cooney TM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Recklitis CJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA., Bober SL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, USA.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Cancer [Cancer] 2024 Sep 01; Vol. 130 (17), pp. 3023-3033. Date of Electronic Publication: 2024 May 28.
Autor:
Newcomb R; Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Traeger L; Department of Psychology, University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida., Jones B; Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Reynolds M; Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Tse A; Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Reese JB; Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Dizon D; Department of Medical Oncology, Lifespan Cancer Institute, Brown University, Providence, Rhode Island., Bober SL; Department of Psychooncolgy and Palliative Care, Dana Farber Cancer Institute, Boston Massachusetts; Harvard Medical School, Boston, Massachusetts., Greer JA; Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Vanderklish J; Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Pensak N; Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., DeFilipp Z; Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Chen YB; Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Temel JS; Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., El-Jawahri A; Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: ael-jawahri@partners.org.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Aug 23. Date of Electronic Publication: 2024 Aug 23.
Autor:
Reese JB; Jennifer B. Reese, PhD, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA; Jessica R. Bauman, MD, Department of Hematology/Oncology, Philadelphia, PA; Kristen A. Sorice, BA, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA; Natasha Frederick, MD, MPH, Center for Cancer & Blood Disorders, Connecticut Children's, University of Connecticut School of Medicine, Hartford, CT; and Sharon L. Bober, PhD, Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA., Bauman JR; Jennifer B. Reese, PhD, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA; Jessica R. Bauman, MD, Department of Hematology/Oncology, Philadelphia, PA; Kristen A. Sorice, BA, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA; Natasha Frederick, MD, MPH, Center for Cancer & Blood Disorders, Connecticut Children's, University of Connecticut School of Medicine, Hartford, CT; and Sharon L. Bober, PhD, Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA., Sorice KA; Jennifer B. Reese, PhD, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA; Jessica R. Bauman, MD, Department of Hematology/Oncology, Philadelphia, PA; Kristen A. Sorice, BA, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA; Natasha Frederick, MD, MPH, Center for Cancer & Blood Disorders, Connecticut Children's, University of Connecticut School of Medicine, Hartford, CT; and Sharon L. Bober, PhD, Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA., Frederick N; Jennifer B. Reese, PhD, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA; Jessica R. Bauman, MD, Department of Hematology/Oncology, Philadelphia, PA; Kristen A. Sorice, BA, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA; Natasha Frederick, MD, MPH, Center for Cancer & Blood Disorders, Connecticut Children's, University of Connecticut School of Medicine, Hartford, CT; and Sharon L. Bober, PhD, Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA., Bober SL; Jennifer B. Reese, PhD, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA; Jessica R. Bauman, MD, Department of Hematology/Oncology, Philadelphia, PA; Kristen A. Sorice, BA, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA; Natasha Frederick, MD, MPH, Center for Cancer & Blood Disorders, Connecticut Children's, University of Connecticut School of Medicine, Hartford, CT; and Sharon L. Bober, PhD, Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Jun; Vol. 20 (6), pp. 870-871. Date of Electronic Publication: 2024 Apr 12.